Tezosentan
- Generic Name
- Tezosentan
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C27H27N9O6S
- CAS Number
- 180384-57-0
- Unique Ingredient Identifier
- 64J9J55263
- Background
Tezosentan is an intravenous endothelin receptor A/B antagonist. Tezosentan was initially developed for vasodilation in patients with acute heart failure but studies have shown that it does not assist in the treatment of dyspnea or prevent cardiovascular events.
- Indication
Investigated for use/treatment in congestive heart failure, liver disease, and heart disease.
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath